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journal homepage: ht tp: / /www.elsevier .com/locate/al i tEditorialInnate lymphoid cells open a new window on allergic diseasesIn Allergology International (AI) Vol. 64 No. 3, we offer a set of re-
view articles entitled “Innate lymphoid cells open a new window
on allergic diseases” as well as original articles and letters to the ed-
itor.We believe that this review series will provide youwith the lat-
est concepts in the area of group 2 innate lymphoid cells, recently
emerged as important in the pathogenesis of allergic diseases.
The ﬁrst evidence of “innate” type 2 immune response was
observed 15 years ago, when interleukin (IL)-25 administered in
mice was found to increase the eosinophil numbers and type-2 cy-
tokines (IL-4, IL-5, IL-13) independently of T and B cells.1 Kondo and
colleagues, in 2008, also reported that IL-33 could induce eosino-
philic inﬂammation in the airways in the absence of lymphocytes,
mast cells, basophils, and other known immune cells.2 These ﬁnd-
ings suggested the presence of an unidentiﬁed innate immune cell
population that produces type-2 cytokines in response to IL-25 and
IL-33 without antigen presentation.
The new era of research on “innate-type allergy” began in 2010
when Moro and colleagues discovered a new type of cells in a
mesenteric lymphoid cluster and named them natural helper
(NH) cells.3 NH cells express neither antigen-speciﬁc receptors
nor lineage markers on the cell surface, but produce large amounts
of IL-5 and IL-13 in response to IL-25 or IL-33. In 2013, innate
lymphoid cells were classiﬁed into three subsets: group 1 cells
that produce IFN-g; group 2 cells that produce IL-4, IL-5, and IL-
13; and group 3 cells that produce IL-17 and/or IL-22.4 NH cells,
nuocytes, and innate helper 2 cells are classiﬁed as group 2 innate
lymphoid cells (ILC2s).
Although ILC2s were ﬁrst described as a part of the innate im-
mune system essential for eliminating intestinal parasites, two
important ﬁndings have suggested possible roles for ILC2s in the
pathophysiology of allergic airway and skin diseases. First, IL-25
and IL-33 can be synthesized in the epithelial and endothelial cells
of these organs in response to non-parasitic microorganisms (vi-
ruses and fungi), protease allergens, or other damage-associated
molecular patterns such as uric acid. Secondly, ILC2s are present
in the upper and lower respiratory tracts and the skin where these
pathologies occur. The review series “Innate lymphoid cells open a
new window on allergic diseases” includes three updated and
detailed review articles about ILC2s and their relationship with
allergic airway diseases, especially asthma and rhinosinusitis. First,
Kita provides information about the role of ILC2s in allergic airway
inﬂammation and allergic diseases caused by fungal allergens.5
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of asthma and in human asthma.6 Matsushita et al. review the role
of ILC2s in two allergic upper respiratory diseases, chronic rhinosi-
nusitis with nasal polyps and allergic rhinitis.7
However, there remain many unresolved questions about ILC2s
and their relationship to allergic diseases. Researchers have yet to
elucidate (1) the interrelationship between ILC2-mediated innate
immune responses and Th2 cell-mediated adaptive immunity; (2)
the homeostatic functions of ILC2s that reside in the respiratory
and digestive organs or the skin, as well as in the brain, heart, mus-
cle, liver, and adipose tissue; (3) the precise distribution and func-
tions of human ILC2s and their relationship to human diseases; or
(4) the possibility of targeting ILC2s to treat allergic diseases.
Two articles regarding eosinophilic gastrointestinal disorders
(EGID) appear in this issue.8,9 EGID are chronic inﬂammatory disor-
ders characterized by primary eosinophilic inﬁltration to the
gastrointestinal (GI) tract without any overt cause. EGID are classi-
ﬁed into eosinophilic esophagitis (EoE), characterized by eosino-
philic inﬁltration limited to esophagus, and eosinophilic
gastroenteritis (EGE), characterized by eosinophilic inﬁltration
into any part of the GI tract. The exact etiology of EGID is unknown,
although it is assumed that EGID has some allergic background.
Moreover, in spite of the recently increased prevalence of EGID as
well as other allergic diseases,10,11 we have only a little epidemio-
logical information about EGID.
Ito et al. searched the literature related to EGID (687 records) us-
ing PubMed and compared Caucasian and Asian (South Korea,
China, Taiwan, and Japan) cases in 121 studies fulﬁlling the eligibility
criteria.8 They found that EoE was dominant in Caucasian cases,
whereas EGEwas dominant in Asian cases, particularly in adults. Ac-
cording to this different distribution, Caucasian cases showed more
dysphagia and heartburn, whereas Asian cases showed more vom-
iting, abdominal pain, and diarrhea. Some factors such as genetic
predisposition, diet habits, or Helicobacter pylori infection may
have caused this difference. Although the exact connection between
etiology and ethnic difference is unknown at this moment, this
ﬁnding shows an important characteristic of EGID.
Shoda et al. assessed the gene proﬁle expressions of esophageal
biopsies from four Japanese adult EoE patients and compared them
with the data fromUS patients with EoE to clarify ethnic differences
with regard to EoE etiology.9 They found that several IL-
13einducible genesdcadherin-like 26, pro-melanin-
concentrating hormone, eotaxin-3, arachidonate-15 lipoxigenase,
periostin, and Charcot-Leyden Criatalsdwere signiﬁcantly upregu-
lated in EoE patients. These genes overlapped very well with the
proﬁles from US patients, although the details of the ethnicvier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
Editorial / Allergology International 64 (2015) 217e218218distribution in US patients are unstated, suggesting that the patho-
genic backgrounds EoE would be the same in Japan and Western
countries. The mystery of how EGID occurs and why the distribu-
tion of EGIDwould differ inWestern and Asian countries continues.
We offer our appreciation to all the authors for their contribu-
tions to the present issue of Allergology International.
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